Clinical characteristics of extracorporeal cardiopulmonary resuscitation in China: a multicenter retrospective study.
Zhiyong Yuan, Ying Liu, Guangyao Wei...
https://pubmed.ncbi.nlm.nih.gov/38987696Actively Recruiting
All Genders
ID04158479
China Extracorporeal Life Support Registry Observational Study on ECMO Use in Heart and Lung Failure
Led by Beijing Anzhen Hospital · Updated on 2024-04-09
20000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is a technique that helps support the heart and lungs in patients with heart failure, lung failure, or both. In China, the use of ECLS has grown over the past decade, with more cases and more centers adopting this technology. This multi-center registry study, led by the Chinese Society of Extracorporeal Life Support, aims to collect data on the use of ECLS in China and evaluate both short-term and long-term patient outcomes. The study includes patients receiving ECMO for different conditions such as acute respiratory failure, acute respiratory distress syndrome (ARDS), heart failure, cardiogenic shock, and cardiac arrest. Data are collected from multiple hospitals across China to capture real-world use of ECMO as a device providing circulatory and respiratory support. Different groups in the registry represent pulmonary support, cardiac support, and extracorporeal cardiopulmonary resuscitation. Participants in the study have their health outcomes observed and recorded, including 30-day and 365-day all-cause mortality, rates of successful ECMO weaning, ECMO-related and other complications, and length of stay in intensive care units and hospitals. This observational study monitors these measures to better understand the effects and outcomes associated with ECMO treatment over time. The study began in 2017 and is planned to continue through 2030.
CONDITIONS
Brief Title
China Extracorporeal Life Support Registry
Who Can Participate
All Genders
Eligibility Criteria
You may qualify if you...
- Patients receiving ECMO for circulatory and/or respiratory support
You will not qualify if you...
- Refusal of consent to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Implementation
Duration - Varies based on treatment duration
Participants receive ECMO support for circulatory and/or respiratory failure as part of routine care. Data on their ECMO treatment and outcomes are collected.
Long-term Monitoring
Duration - Up to 365 days
Participants are observed for short-term and long-term outcomes following ECMO treatment, including mortality and complications up to 365 days.
Trial Site Locations
Total: 1 location
1
Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100029
Actively Recruiting
Loading map...
Research Team
X
Xiaotong Hou, MD., PhD.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here